ポスト
Since the FDA cleared Sarepta Thereapeutics' gene therapy for nearly all people with Duchenne, its stock price has tanked. https://t.co/7yf26oUXRy
メニューを開くSince the FDA cleared Sarepta Thereapeutics' gene therapy for nearly all people with Duchenne, its stock price has tanked. https://t.co/7yf26oUXRy
メニューを開く
